LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Sissejuhatus

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties või psychedelic compounds. Production takes place under strict quality control.

Tehnilised andmed

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Puhtus: ≥98% (HPLC analüüsitud)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Teadustöö rakendused

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Kvaliteedikontroll

Iga partii suhtes kohaldatakse:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Ohutusprotokoll

Käitlemine

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Ladustamine

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Regulatiivne raamistik

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Ei sobi inimtoiduks
• Export and distribution subject to regulations

Tellimuse teave

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Teaduslikud viited

• Nichols (2016) – Psühhedeelikumid ravimitena
• Brandt jt (2020) – Lüsergamiidi farmakoloogia
• EMCDDA (2023) – Uute psühhoaktiivsete ainete tehniline aruanne

Oluline märkus

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG kunstipaberit O-DSMT 50 mg graanulid 1V-LSD 150 MCG blotterid 6-CL-ADBA 2-CMC 250 mg graanulid